Chemokine signaling in cancer-stroma communications
Author:
Funder
Pharmaceutical Research and Manufacturers of America Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology,Biochemistry
Link
https://link.springer.com/content/pdf/10.1007/s12079-021-00621-7.pdf
Reference217 articles.
1. Ahirwar DK, Nasser MW, Ouseph MM et al (2018) Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene 37:4428–4442. https://doi.org/10.1038/s41388-018-0263-7
2. Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787–820. https://doi.org/10.1146/annurev.immunol.24.021605.090529
3. Angiolillo AL, Sgadari C, Taub DD et al (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182:155–162. https://doi.org/10.1084/jem.182.1.155
4. Araujo JM, Gomez AC, Aguilar A et al (2018) Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer. Sci Rep 8:4899. https://doi.org/10.1038/s41598-018-23099-7
5. Awaji M, Futakuchi M, Heavican T et al (2019) Cancer-associated fibroblasts enhance survival and progression of the aggressive pancreatic tumor via FGF-2 and CXCL8. Cancer Microenviron 12:37–46. https://doi.org/10.1007/s12307-019-00223-3
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies;Cancer Science;2024-08-25
2. Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance;Cancers;2024-08-08
3. Skin Telocytes Could Fundament the Cellular Mechanisms of Wound Healing in Platelet-Rich Plasma Administration;Cells;2024-08-08
4. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2024-05-15
5. Pentixather: paving the way for radioligand therapy in oncohematology;Expert Review of Anticancer Therapy;2024-04-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3